Community/Retail

Dennis Killian, PharmD, PhD, Director of Pharmacy Services, Peninsula Regional Medical Center, Salisbury, MD, discusses techniques to optimize the use of IV robotics in a hospital pharmacy setting.

Officials with the FDA issued a statement to clarify data accuracy issues with recently-approved gene therapy Zolgensma (onasemnogene abeparvovec-xioi, AveXis), a product intended to treat spinal muscular atrophy (SMA) in children under 2 years old.

Tera Moore, PharmD, National Program Manager, VA Pharmacy Benefits Management office, discusses the shortage of psychiatrists and how integration of mental health professionals could help solve the issue.

Katie Westgerdes, PharmD, pharmacist at the ONU Healthwise Pharmacy, discusses the Cardinal Health generic brand products, LEADER, and their place in the ONU Healthwise Pharmacy during the 2019 Cardinal Health Retail Business Conference.

Julie Johnson, PharmD, Dean of the University of Florida College of Pharmacy, speaks about the various goals of precision medicine, and how pharmacists can implement precision medicine to improve patient health.

Officials with the FDA have granted approval to pexidartinib (Turalio, Daiichi Sankyo) capsules for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not responsive to improvement with surgery.

Larry Schieber, RPh, pharmacist and owner of Shieber Pharmacy in Circleville, OH discusses the importance of the Generation Rx materials in drug abuse prevention at the Cardinal Health Retail Business Conference in Nashville, TN on July 19, 2019.